Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06985875 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

Study acronym: DROP04
StatusNot Yet Recruiting
PhasePhase 3
SponsorAvizor SA
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 9, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 2025 to Jul 2025v4
  2. Secondary endpoints revised (5)v3
  3. Interventions: Multidose moisturizing solution Avizor Eye Drops 0.2% Preserved (Device), Multidose moisturizing solution DROP 0.4% HA-PB (Device) to Multidose mosturizing solution Avizor Eye Drops 0.2% Preserved (Device), Multidose mosturizing solution DROP 0.4% (Device)
    • Secondary endpoints revised (5)
    • Study title shortened, about 8 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Avizor SA
2 trials monitored
See all monitored trials
The aim of the trial is to compare the safety and efficacy of the moisturizing solution DROP 0.4% with the moisturizing solution AVIZOR EYE DROPS 0.2% PRESERVED in relieving the symptoms of dry eye over one month of use.
Trial Details
NCT Number NCT06985875
Lead Sponsor Avizor SA
Collaborators: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Conditions
(from sponsor)		 Eye Dryness
Related terms Dry Eye Syndromes, Xerophthalmia
Enrollment 79 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov